Literature DB >> 23241992

Chronic recurrent multifocal osteomyelitis and deficiency of interleukin-1-receptor antagonist.

Waheeb Sakran, Stavit A Shalev, Waheeb Sakran, Stavit A Shalev, Hatem El-Shanti, Yosef Uziel, Yosef Uziel.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23241992     DOI: 10.1097/INF.0b013e3182700cc1

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  7 in total

Review 1.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

Review 2.  Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers.

Authors:  Manisha Sharma; Polly J Ferguson
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

Review 3.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130

4.  Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report.

Authors:  Ezgi Ulusoy; Neslihan Edeer Karaca; Hatem El-Shanti; Erhan Kilicoglu; Guzide Aksu; Necil Kutukculer
Journal:  J Med Case Rep       Date:  2015-06-23

Review 5.  Majeed Syndrome: A Review of the Clinical, Genetic and Immunologic Features.

Authors:  Polly J Ferguson; Hatem El-Shanti
Journal:  Biomolecules       Date:  2021-02-28

Review 6.  New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations.

Authors:  Wei Cheng; Fen Li; Jing Tian; Xi Xie; Jin-Wei Chen; Xiao-Fei Peng; Qi Tang; Yan Ge
Journal:  J Inflamm Res       Date:  2022-04-13

Review 7.  Anakinra Therapy for Non-cancer Inflammatory Diseases.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.